Matti Hero Selected Research

Bone Resorption

1/2009

Impact of aromatase inhibitor therapy on bone turnover, cortical bone growth and vertebral morphology in pre- and peripubertal boys with idiopathic short stature.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Matti Hero Research Topics

Disease

4	Hypogonadism (Hypergonadotropic Hypogonadism) 01/2019 - 05/2012
4	Congenital Abnormalities (Deformity) 01/2019 - 01/2009
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2021 - 01/2020
2	Precocious Puberty 01/2021 - 10/2011
2	Hyperandrogenism 10/2011 - 11/2006
2	Congenital Adrenal Hyperplasia (Hyperplasia, Congenital Adrenal) 10/2011 - 09/2005
2	Growth Disorders 07/2010 - 09/2006
1	Obesity 03/2022
1	Hypopituitarism (Sheehan's Syndrome) 01/2020
1	Combined Pituitary Hormone Deficiency 01/2020
1	Penis agenesis 12/2018
1	Gingival Fibromatosis 01/2018
1	Amenorrhea 01/2017
1	Craniopharyngioma (Craniopharyngiomas) 01/2017
1	Gynecomastia 10/2011
1	Polyostotic Fibrous Dysplasia (McCune Albright Syndrome) 10/2011
1	Familial Testotoxicosis 10/2011
1	Breast Neoplasms (Breast Cancer) 10/2011
1	Ovarian Cysts (Ovarian Cyst) 10/2011
1	Polycythemia (Erythrocytosis) 10/2011
1	Peutz-Jeghers Syndrome (Polyposis, Hamartomatous Intestinal) 10/2011
1	Osteogenesis Imperfecta (Lobstein Disease) 01/2011
1	Osteoporosis 01/2011
1	Compression Fractures (Compression Fracture) 07/2010
1	Bone Resorption 01/2009
1	Klinefelter Syndrome (Klinefelter's Syndrome) 11/2006
1	Insulin Resistance 09/2006
1	Perinatal Death 03/2005
1	Adrenal Insufficiency (Adrenal Gland Hypofunction) 03/2005

Drug/Important Bio-Agent (IBA)

4	Aromatase InhibitorsIBA 10/2011 - 09/2006
4	Letrozole (Femara)FDA LinkGeneric 10/2011 - 11/2006
2	Growth Hormone (Somatotropin)IBA 01/2020 - 01/2018
2	Hormones (Hormone)IBA 01/2020 - 05/2012
2	Human Follicle Stimulating HormoneIBA 01/2019 - 12/2018
2	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2017 - 01/2017
2	inhibin BIBA 01/2017 - 05/2012
1	Ghrelin ReceptorsIBA 03/2022
1	Antimicrobial PeptidesIBA 03/2022
1	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 01/2021
1	Hemoglobins (Hemoglobin)IBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 01/2018
1	GonadotropinsIBA 01/2017
1	HDL CholesterolIBA 10/2011
1	Anastrozole (Arimidex)FDA LinkGeneric 10/2011
1	due to increased aromatase activity familial gynecomastiaIBA 10/2011
1	Diphosphonates (Bisphosphonates)IBA 01/2011
1	Zoledronic Acid (Zometa)FDA Link 01/2011
1	Pamidronate (Aredia)FDA LinkGeneric 01/2011
1	Estrogens (Estrogen)FDA Link 07/2010
1	N-propeptide type I collagenIBA 01/2009
1	Biomarkers (Surrogate Marker)IBA 01/2009
1	Alkaline PhosphataseIBA 01/2009
1	Collagen Type I (Type I Collagen)IBA 01/2009
1	Insulin (Novolin)FDA Link 11/2006
1	Aromatase (CYP19)IBA 09/2006
1	AndrogensIBA 09/2006
1	AdiponectinIBA 09/2006
1	Flutamide (Eulexin)FDA LinkGeneric 09/2005
1	Adrenocorticotropic Hormone (ACTH)FDA Link 03/2005
1	GlucocorticoidsIBA 03/2005

Therapy/Procedure

4	Therapeutics 01/2019 - 11/2006
1	Caloric Restriction 03/2022
1	Glycemic Control 01/2021
1	Orchiopexy 12/2018
1	Off-Label Use 10/2011